Opendata, web and dolomites

BIOREMIA SIGNED

BIOfilm-REsistant Materials for hard tissue Implant Applications

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 BIOREMIA project word cloud

Explore the words cloud of the BIOREMIA project. It provides you a very rough idea of what is the project "BIOREMIA" about.

transferable    caused    disciplinary    links    austria    germany    inter    ireland    experts    regulation    skills    employers    minimizing    scientific    productivity    spain    nanotechnology    surfaces    implant    industry    technologies    forming    esrs    career    courses    dental    joint    citizens    careers    infection    attractive    uk    delivering    greece    training    involvement    strategies    antibacterial    biomaterials    combining    italy    network    class    biofilm    usa    consulting    bioremia    hands    rates    netherlands    society    biotechnology    microbiology    trained    bacteria    device    innovation    successful    recruit    11    young    industrial    sweden    participating    mind    world    entrepreneurship    supervised    doctoral    medical    education    ipr    students    holistic    countries    phd    academic    oriented    engineering    communication    15    doors    beneficiaries    infections    complemented    healthcare    patient    switzerland    innovative    online    perspective    biochemistry    france    orthopaedic    surface    manufacturing    materials   

Project "BIOREMIA" data sheet

The following table provides information about the project.

Coordinator
LEIBNIZ-INSTITUT FUER FESTKOERPER- UND WERKSTOFFFORSCHUNG DRESDEN E.V. 

Organization address
address: HELMHOLTZSTRASSE 20
city: DRESDEN
postcode: 1069
website: www.ifw-dresden.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 4˙029˙973 €
 EC max contribution 4˙029˙973 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2019
 Funding Scheme MSCA-ITN-ETN
 Starting year 2020
 Duration (year-month-day) from 2020-01-01   to  2023-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LEIBNIZ-INSTITUT FUER FESTKOERPER- UND WERKSTOFFFORSCHUNG DRESDEN E.V. DE (DRESDEN) coordinator 505˙576.00
2    THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE UK (CAMBRIDGE) participant 606˙345.00
3    GOETEBORGS UNIVERSITET SE (GOETEBORG) participant 563˙965.00
4    UNIVERSIDAD AUTONOMA DE BARCELONA ES (CERDANYOLA DEL VALLES) participant 501˙809.00
5    PX SERVICES SA CH (LA CHAUX-DE-FONDS) participant 281˙276.00
6    ANTHOGYR SAS FR (SALLANCHES) participant 274˙802.00
7    ASHLAND SPECIALTIES IRELAND LIMITED IE (Dublin) participant 274˙684.00
8    MONTANUNIVERSITAET LEOBEN AT (LEOBEN) participant 264˙207.00
9    UNIVERSITA DEGLI STUDI DI TORINO IT (TORINO) participant 261˙499.00
10    STRYKER TRAUMA GMBH DE (SCHONKIRCHEN) participant 252˙788.00
11    PANEPISTIMIO IOANNINON EL (IOANNINA) participant 243˙017.00

Map

 Project objective

Implant-associated infections, commonly caused by biofilm-forming bacteria, are highly problematic for the patient, the healthcare system, and society. BIOREMIA will recruit 15 doctoral students (ESRs) and provide a highly inter-disciplinary joint research & training programme focused on the key issues that determine the future antibacterial biomaterials and technologies for orthopaedic and dental applications. BIOREMIA links 7 academic and 4 non-academic beneficiaries as well as 6 partners from 11 European countries (Germany, Austria, Greece, Sweden, UK, Spain, Italy, France, Switzerland, Ireland and the Netherlands) and the USA. The ESRs will be supervised and trained by world-class academic and industrial organisations, combining technical knowledge with hands-on training in state-of-the-art research projects. BIOREMIA training program will include face-to-face and online scientific courses in biomaterials & surface engineering, biotechnology,nanotechnology, implant manufacturing, biochemistry, microbiology and biofilm. This will be complemented by education in transferable skills such as entrepreneurship, management, IPR, communication etc. useful for getting an innovation-oriented mind-set of young researchers. Participating in BIOREMIA will make PhD students highly attractive for employers and open up doors for their successful careers in research, regulation, consulting, industry and the healthcare system. They will be experts for the better assessment of the antibacterial functionality of materials and surfaces and for delivering successful strategies for the medical device industry and the healthcare system. The strong involvement of the industrial sector will provide the ESRs with a holistic perspective on career opportunities. Beyond the trained researchers, this network will produce innovative materials and technologies that will enhance the productivity of European industry and improve the well-being of European citizens by minimizing implant-associated infection rates.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BIOREMIA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BIOREMIA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

SAMCAPS (2018)

Self-Assembled MicroCAPSules: Synthesis, Characterization, and Eco-friendly Application in Home Care Products

Read More  

NU-SPINE (2019)

Training innovative future leaders in research and development of materials and implants for the spine

Read More  

INSPIRE (2020)

INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition.

Read More